Test of Novel Drug for Smoking Cessation

NCT02217527 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: Active JNJ Drug
DRUG: Placebo pill

Sponsor

Chengappa, K.N. Roy, MD

Collaborators

[object Object]